$BIIB Recent Headlines Biogen results crush co
Post# of 89362
Posted On: 07/24/2014 11:07:54 AM
$BIIB Recent Headlines
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang
Stock Market News for July 24, 2014 - Market News 57 min ago - Zacks.com
Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog 9:50 a.m. Today - Zacks.com
Zacks Rank #1 Additions for Thursday - Tale of the Tape 9:30 a.m. Today - Zacks.com
The Medicines Co.'s (MDCO) Q2 Earnings Decline Y/Y - Analyst Blog 9:20 a.m. Today - Zacks.com
Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher - Tale of the Tape 9:11 a.m. Today - Zacks.com
Biogen Idec (BIIB) Soars: Stock Adds 11.2% in Session - Tale of the Tape 8:51 a.m. Today - Zacks.com
Time to Focus on Biogen Idec (BIIB) for Strong Earnings Growth Potential - Tale of the Tape 8:48 a.m. Today - Zacks.com
Cramer's Mad Money: The 4 Horsemen Trample Big Pharma (7/23/14) 6:01 a.m. Today - Seeking Alpha
Jim Cramer's Top Stock Picks: PEP CELG GILD REGN BIIB CMG 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom 8:05 p.m. July 23, 2014 - TheStreet.com
Avanir to Conduct Phase II Study on AVP-786 for Depression - Analyst Blog 5:50 p.m. July 23, 2014 - Zacks.com
Biogen, Gilead Crush Earnings Estimates On Hot Drugs 5:17 p.m. July 23, 2014 - Investors Business Daily
10-Q: BIOGEN IDEC INC. 4:24 p.m. July 23, 2014 - Edgar Online - (EDG = 10Q, 10K)
Can't Find an Edge 4:20 p.m. July 23, 2014 - RealMoney.com
Biogen's Results Cure Some Pain 4:00 p.m. July 23, 2014 - Seeking Alpha
Biogen Idec's (BIIB) CEO George Scangos on Q2 2014 Results - Earnings Call Transcript 3:52 p.m. July 23, 2014 - Seeking Alpha
Biogen Idec Beats And Raises: Reassessing Its Prospects 3:43 p.m. July 23, 2014 - Seeking Alpha
IPO Stock Watch: Biotechs Are Half Of July Calendar 3:07 p.m. July 23, 2014 - Investors Business Daily
Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst Blog 2:15 p.m. July 23, 2014 - Zacks.com
Biogen Trounces Q2 Estimates As Tecfidera Outperforms 10:56 a.m. July 23, 2014 - Investors Business Daily
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept 8:40 a.m. July 17, 2014 - PR Newswire - PRF
Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple Sclerosis (MS) 8:01 a.m. July 16, 2014 - BusinessWire - BZX
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses 5:00 a.m. July 2, 2014 - BusinessWire - BZX
Biogen Idec to Report Second Quarter 2014 Financial Results on July 23, 2014 4:01 p.m. June 30, 2014 - BusinessWire - BZX
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration agreement with Biogen Idec 2:01 a.m. June 16, 2014 - Thomson Reuters ONE
One Year Post-Launch, All Surveyed U.S. Neurologists Report Having Clinical Experience with Biogen Idec's Tecfidera for the Treatment of Multiple Sclerosis 12:00 p.m. June 12, 2014 - PR Newswire - PRF
FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna 5:10 a.m. June 11, 2014 - PR Newswire - PRF
RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology 5:00 a.m. June 11, 2014 - BusinessWire - BZX
The Pulmonary Fibrosis Foundation Receives Grant From Biogen Idec To Support The PFF Patient Registry 11:00 a.m. June 10, 2014 - PR Newswire - PRF
Increased Credit Facility Commitments, Positions Moved, Survey Results, LEED Certification, and New Board Member Election - Analyst Notes on Prospect, Waddell & Reed, SEI, Alexandria and RPAI 5:20 a.m. June 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1 7:00 a.m. June 9, 2014 - PR Newswire - PRF
The US Food and Drug Administration (FDA) approves Eloctate(TM) 2:02 a.m. June 9, 2014 - Thomson Reuters ONE
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang
Stock Market News for July 24, 2014 - Market News 57 min ago - Zacks.com
Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog 9:50 a.m. Today - Zacks.com
Zacks Rank #1 Additions for Thursday - Tale of the Tape 9:30 a.m. Today - Zacks.com
The Medicines Co.'s (MDCO) Q2 Earnings Decline Y/Y - Analyst Blog 9:20 a.m. Today - Zacks.com
Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher - Tale of the Tape 9:11 a.m. Today - Zacks.com
Biogen Idec (BIIB) Soars: Stock Adds 11.2% in Session - Tale of the Tape 8:51 a.m. Today - Zacks.com
Time to Focus on Biogen Idec (BIIB) for Strong Earnings Growth Potential - Tale of the Tape 8:48 a.m. Today - Zacks.com
Cramer's Mad Money: The 4 Horsemen Trample Big Pharma (7/23/14) 6:01 a.m. Today - Seeking Alpha
Jim Cramer's Top Stock Picks: PEP CELG GILD REGN BIIB CMG 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom 8:05 p.m. July 23, 2014 - TheStreet.com
Avanir to Conduct Phase II Study on AVP-786 for Depression - Analyst Blog 5:50 p.m. July 23, 2014 - Zacks.com
Biogen, Gilead Crush Earnings Estimates On Hot Drugs 5:17 p.m. July 23, 2014 - Investors Business Daily
10-Q: BIOGEN IDEC INC. 4:24 p.m. July 23, 2014 - Edgar Online - (EDG = 10Q, 10K)
Can't Find an Edge 4:20 p.m. July 23, 2014 - RealMoney.com
Biogen's Results Cure Some Pain 4:00 p.m. July 23, 2014 - Seeking Alpha
Biogen Idec's (BIIB) CEO George Scangos on Q2 2014 Results - Earnings Call Transcript 3:52 p.m. July 23, 2014 - Seeking Alpha
Biogen Idec Beats And Raises: Reassessing Its Prospects 3:43 p.m. July 23, 2014 - Seeking Alpha
IPO Stock Watch: Biotechs Are Half Of July Calendar 3:07 p.m. July 23, 2014 - Investors Business Daily
Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst Blog 2:15 p.m. July 23, 2014 - Zacks.com
Biogen Trounces Q2 Estimates As Tecfidera Outperforms 10:56 a.m. July 23, 2014 - Investors Business Daily
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept 8:40 a.m. July 17, 2014 - PR Newswire - PRF
Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple Sclerosis (MS) 8:01 a.m. July 16, 2014 - BusinessWire - BZX
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses 5:00 a.m. July 2, 2014 - BusinessWire - BZX
Biogen Idec to Report Second Quarter 2014 Financial Results on July 23, 2014 4:01 p.m. June 30, 2014 - BusinessWire - BZX
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration agreement with Biogen Idec 2:01 a.m. June 16, 2014 - Thomson Reuters ONE
One Year Post-Launch, All Surveyed U.S. Neurologists Report Having Clinical Experience with Biogen Idec's Tecfidera for the Treatment of Multiple Sclerosis 12:00 p.m. June 12, 2014 - PR Newswire - PRF
FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna 5:10 a.m. June 11, 2014 - PR Newswire - PRF
RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology 5:00 a.m. June 11, 2014 - BusinessWire - BZX
The Pulmonary Fibrosis Foundation Receives Grant From Biogen Idec To Support The PFF Patient Registry 11:00 a.m. June 10, 2014 - PR Newswire - PRF
Increased Credit Facility Commitments, Positions Moved, Survey Results, LEED Certification, and New Board Member Election - Analyst Notes on Prospect, Waddell & Reed, SEI, Alexandria and RPAI 5:20 a.m. June 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1 7:00 a.m. June 9, 2014 - PR Newswire - PRF
The US Food and Drug Administration (FDA) approves Eloctate(TM) 2:02 a.m. June 9, 2014 - Thomson Reuters ONE
(0)
(0)